Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 443 to 492 of 3228 in total 
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NAV2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuron navigator 2 isoform l; retinoic acid inducible in neuroblastoma; pore membrane and/or filament interacting like protein 2; helicase helad1. [source:refseq;acc:nm\_145117]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
223.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.539\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0783\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NAV1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuron navigator 1; neuron navigator-1; pore membrane and/or filament interacting like protein 3. [source:refseq;acc:nm\_020443]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.801\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.549\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NAV3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuron navigator 3; pore membrane and/or filament interacting like protein 1; steerin 3. [source:refseq;acc:nm\_014903]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GRB2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
growth factor receptor-bound protein 2 (grb2 adapter protein) (sh2/sh3 adapter grb2) (ash protein). [source:swissprot;acc:p29354]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.049\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.785\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07827\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NEK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase nek2 (ec 2.7.1.37) (nima-related protein kinase 2) (nima-like protein kinase 1) (hspk 21). [source:swissprot;acc:p51955]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MACF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
microtubule-actin crosslinking factor 1, isoform 4. [source:swissprot;acc:q96pk2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.468\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
246.338\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07822\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DST\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bullous pemphigoid antigen 1 isoforms 1/2/3/4/5/8 (230 kda bullous pemphigoid antigen) (bpa) (hemidesmosomal plaque protein) (dystonia musculorum protein) (fragment). [source:swissprot;acc:q03001]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
228.463\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
246.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07821\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRP9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07815\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR3C\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (62kd). [source:refseq;acc:nm\_006468]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.092\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
257.705\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07785\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ba395l14.12 (novel protein similar to small nuclear ribonucleoprotein polypeptide a' (snrpa1)). [source:sptrembl;acc:q9nu36]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
224.161\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.972\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07784\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
453\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SNRPA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
u2 small nuclear ribonucleoprotein a' (u2 snrnp-a'). [source:swissprot;acc:p09661]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s26. [source:swissprot;acc:p02383]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.224\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
226.578\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07779\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
455\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TIMM22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial import inner membrane translocase subunit tim22. [source:swissprot;acc:q9y584]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
210.225\vspace{3pt}}}&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
456\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATPAF2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp synthase mitochondrial f1 complex assembly factor 2. [source:refseq;acc:nm\_145691]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
457\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UQCRB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ubiquinol-cytochrome c reductase complex 14 kda protein (ec 1.10.2.2) (complex iii subunit vi) (qp-c). [source:swissprot;acc:p14927]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
458\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SRP9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
signal recognition particle 9 kda protein (srp9). [source:swissprot;acc:p49458]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
235.922\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.925\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07764\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
459\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BAG3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-3 (bcl-2 binding athanogene- 3) (bag-3) (bcl-2-binding protein bis) (docking protein cair-1). [source:swissprot;acc:o95817]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.737\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07748\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SF3A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
splicing factor 3a subunit 2 (spliceosome associated protein 62) (sap 62) (sf3a66). [source:swissprot;acc:q15428]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
223.648\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
207.62\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.0772\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
461\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KLF5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
krueppel-like factor 5 (intestinal-enriched krueppel-like factor) (colon krueppel-like factor) (transcription factor bteb2) (basic transcription element binding protein 2) (bte-binding protein 2) (gc box binding protein 2). [source:swissprot;acc:q13887]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
462\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MKI67IP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mki67 (fha domain) interacting nucleolar phosphoprotein; nucleolar phosphoprotein nopp34; nucleolar protein interacting with the fha domain of pki-67. [source:refseq;acc:nm\_032390]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
254.434\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.224\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07709\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
463\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR3F\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerases iii 39 kda polypeptide (ec 2.7.7.6) (rna polymerase iii c39 subunit). [source:swissprot;acc:q9h1d9]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
238.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
257.327\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07704\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
464\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FNBP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ba138e2.1.2 (formin-binding protein 17 (fbp17), isoform 2). [source:sptrembl;acc:q96lh6]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.578\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
226.764\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07686\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
465\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CHRNA7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuronal acetylcholine receptor protein, alpha-7 chain precursor. [source:swissprot;acc:p36544]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
248.152\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
267.226\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
466\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADCY6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylate cyclase, type vi (ec 4.6.1.1) (atp pyrophosphate-lyase) (ca(2+)-inhibitable adenylyl cyclase). [source:swissprot;acc:o43306]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
467\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADCY5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adenylate cyclase, type v (ec 4.6.1.1) (atp pyrophosphate-lyase) (adenylyl cyclase) (fragment). [source:swissprot;acc:o95622]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
468\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LRRC15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
leucine-rich repeat-containing protein 15 precursor (hlib). [source:swissprot;acc:q8tf66]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
469\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FEM1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
470\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LRRC3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
leucine-rich repeat protein lrrc3 precursor. [source:swissprot;acc:q9by71]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
471\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LAMC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
laminin gamma-1 chain precursor (laminin b2 chain). [source:swissprot;acc:p11047]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
472\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC46A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
thymic stromal co-transporter. [source:refseq;acc:nm\_033051]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
473\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRPF31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-mrna processing factor 31 homolog; pre-mrna processing factor 31 homolog (yeast). [source:refseq;acc:nm\_015629]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.651\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07637\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
474\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.789\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.818\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07576\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
475\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.727\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.816\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07547\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
476\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KCNA4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
potassium voltage-gated channel subfamily a member 4 (potassium channel kv1.4) (hk1) (hpcn2) (hbk4) (hukii). [source:swissprot;acc:p22459]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
226.681\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.814\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07527\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
477\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NIP7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.926\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.547\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
478\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BRF1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
228.051\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.321\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07409\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
479\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOLA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
480\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NETO2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 2 precursor. [source:refseq;acc:nm\_018092]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
237.109\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
254.667\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07405\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
481\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NETO1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 1 isoform 3 precursor. [source:refseq;acc:nm\_138966]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
482\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRNPU\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
heterogenous nuclear ribonucleoprotein u (hnrnp u) (scaffold attachment factor a) (saf-a). [source:swissprot;acc:q00839]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
483\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUNX2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
runt-related transcription factor 2 (core-binding factor, alpha 1 subunit) (cbf-alpha 1) (acute myeloid leukemia 3 protein) (oncogene aml-3) (polyomavirus enhancer binding protein 2 alpha a subunit) (pebp2-alpha a) (pea2-alpha a) (sl3-3 enhancer factor 1 alpha a subunit) (sl3/akv core-binding factor alpha a subunit) (osteoblast- specific transcription factor 2) (osf-2). [source:swissprot;acc:q13950]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
484\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HNRPUL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
e1b-55kda-associated protein 5 isoform a. [source:refseq;acc:nm\_007040]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
485\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPL18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
60s ribosomal protein l18. [source:swissprot;acc:q07020]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
486\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MCTS1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mct-1 protein. [source:refseq;acc:nm\_014060]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
226.313\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
243.03\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.07387\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
487\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRPL22\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
mitochondrial ribosomal protein l22. [source:refseq;acc:nm\_014180]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
488\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SART1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
squamous cell carcinoma antigen recognized by t cells 1; u4/u6.u5 tri-snrnp-associated 110 kda protein; ige autoantigen; sart1(259) protein; sart1(800) protein. [source:refseq;acc:nm\_005146]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
225.026\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
209.798\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
489\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PPM1B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein phosphatase 2c beta isoform (ec 3.1.3.16) (pp2c-beta). [source:swissprot;acc:o75688]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
231.276\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07257\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
490\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARHGEF7\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 7 (pak-interacting exchange factor beta) (beta-pix) (cool-1) (p85). [source:swissprot;acc:q14155]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.183\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.015\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0719\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
491\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTPBP4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb). [source:swissprot;acc:q9bze4]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
234.951\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.07184\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
492\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PAK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 2 (ec 2.7.1.-) (p21-activated kinase 2) (pak-2) (pak65) (gamma-pak) (s6/h4 kinase). [source:swissprot;acc:q13177]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.171\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
235.979\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0718\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/